Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) ...
The Columbus Blue Jackets face the Carolina Hurricanes for a matchup within the Metropolitan Division Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback